[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO20001171D0 - FremgangsmÕte ved økning av benvolum under anvendelse av ikke naturlig forekommende FP-selektive agonister - Google Patents

FremgangsmÕte ved økning av benvolum under anvendelse av ikke naturlig forekommende FP-selektive agonister

Info

Publication number
NO20001171D0
NO20001171D0 NO20001171A NO20001171A NO20001171D0 NO 20001171 D0 NO20001171 D0 NO 20001171D0 NO 20001171 A NO20001171 A NO 20001171A NO 20001171 A NO20001171 A NO 20001171A NO 20001171 D0 NO20001171 D0 NO 20001171D0
Authority
NO
Norway
Prior art keywords
procedure
naturally occurring
bone volume
increasing bone
selective agonists
Prior art date
Application number
NO20001171A
Other languages
English (en)
Other versions
NO20001171L (no
Inventor
James Richard Hartke
Mark Walden Lundy
Mitchell Anthony Delong
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO20001171D0 publication Critical patent/NO20001171D0/no
Publication of NO20001171L publication Critical patent/NO20001171L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20001171A 1997-09-09 2000-03-07 FremgangsmÕte ved økning av benvolum under anvendelse av ikke naturlig forekommende FP-selektive agonister NO20001171L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5830697P 1997-09-09 1997-09-09
PCT/US1998/018338 WO1999012551A1 (en) 1997-09-09 1998-09-04 Method of increasing bone volume using non-naturally-occurring fp selective agonists

Publications (2)

Publication Number Publication Date
NO20001171D0 true NO20001171D0 (no) 2000-03-07
NO20001171L NO20001171L (no) 2000-05-09

Family

ID=22015996

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20001171A NO20001171L (no) 1997-09-09 2000-03-07 FremgangsmÕte ved økning av benvolum under anvendelse av ikke naturlig forekommende FP-selektive agonister

Country Status (20)

Country Link
US (1) US6156799A (no)
EP (1) EP1045694A1 (no)
JP (1) JP2001515864A (no)
KR (1) KR20010023840A (no)
CN (1) CN1269721A (no)
AR (1) AR013479A1 (no)
AU (1) AU739275B2 (no)
BR (1) BR9811780A (no)
CA (1) CA2303800A1 (no)
CO (1) CO4980882A1 (no)
HU (1) HUP0004581A2 (no)
ID (1) ID24827A (no)
IL (1) IL134760A0 (no)
NO (1) NO20001171L (no)
PE (1) PE119099A1 (no)
PL (1) PL339288A1 (no)
SK (1) SK3412000A3 (no)
TR (1) TR200000662T2 (no)
WO (1) WO1999012551A1 (no)
ZA (1) ZA988228B (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL145122A0 (en) 1999-03-05 2002-06-30 Procter & Gamble C16 unsaturated fp-selective prostaglandin analogs
JP2002538138A (ja) * 1999-03-05 2002-11-12 ザ プロクター アンド ギャンブル カンパニー Ｃ１６不飽和ｆｐ−選択的プロスタグランジン類縁体
JP2002538105A (ja) * 1999-03-05 2002-11-12 ザ プロクター アンド ギャンブル カンパニー 骨体積の増加のための天然に存在しないｅｐ１選択的アゴニストの使用
WO2000051616A1 (en) * 1999-03-05 2000-09-08 The Procter & Gamble Company Method of increasing bone volume using non-naturally-occurring selective fp agonist and dito ep1 agonist prostaglandin derivatives
CA2303060A1 (en) * 1999-04-14 2000-10-14 United States Gear Corporation Towed vehicle brake controller
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US6904123B2 (en) 2000-08-29 2005-06-07 Imaging Therapeutics, Inc. Methods and devices for quantitative analysis of x-ray images
US7467892B2 (en) 2000-08-29 2008-12-23 Imaging Therapeutics, Inc. Calibration devices and methods of use thereof
JP4049312B2 (ja) 2000-08-29 2008-02-20 イメージング セラピューティクス，インコーポレーテッド Ｘ線画像の定量解析法および装置
US8639009B2 (en) 2000-10-11 2014-01-28 Imatx, Inc. Methods and devices for evaluating and treating a bone condition based on x-ray image analysis
US7660453B2 (en) 2000-10-11 2010-02-09 Imaging Therapeutics, Inc. Methods and devices for analysis of x-ray images
US8000766B2 (en) 2001-05-25 2011-08-16 Imatx, Inc. Methods to diagnose treat and prevent bone loss
CN1893977B (zh) * 2001-07-23 2012-12-05 小野药品工业株式会社 以ep4激动剂为活性成分的治疗与骨质损失有关的疾病的药物
KR20070087078A (ko) 2001-07-23 2007-08-27 오노 야꾸힝 고교 가부시키가이샤 Ｅｐ４ 아고니스트를 유효 성분으로 하는 골량 저하 질환의치료제
AU2003241273A1 (en) * 2002-02-07 2003-09-09 Rutgers, The State University Of New Jersey Therapeutical polyanhydride compounds for drug delivery
US7840247B2 (en) 2002-09-16 2010-11-23 Imatx, Inc. Methods of predicting musculoskeletal disease
US8965075B2 (en) 2002-09-16 2015-02-24 Imatx, Inc. System and method for predicting future fractures
CA2519187A1 (en) 2003-03-25 2004-10-14 Imaging Therapeutics, Inc. Methods for the compensation of imaging technique in the processing of radiographic images
WO2005027732A2 (en) * 2003-09-19 2005-03-31 Imaging Therapeutics, Inc. Method for bone structure prognosis and simulated bone remodeling
US8290564B2 (en) 2003-09-19 2012-10-16 Imatx, Inc. Method for bone structure prognosis and simulated bone remodeling
EP1789924A2 (en) 2004-09-16 2007-05-30 Imaging Therapeutics, Inc. System and method of predicting future fractures
EP2061376A2 (en) * 2006-09-15 2009-05-27 Imaging Therapeutics, Inc. Method and system for providing fracture/no fracture classification
US8939917B2 (en) 2009-02-13 2015-01-27 Imatx, Inc. Methods and devices for quantitative analysis of bone and cartilage

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4621100A (en) * 1981-09-25 1986-11-04 The Upjohn Company Treatment of osteoporosis with prostaglandins
AU3607293A (en) * 1992-02-05 1993-09-03 Merck & Co., Inc. Implant therapy for bone growth stimulation
US5310759A (en) * 1992-08-12 1994-05-10 Bockman Richard S Methods of protecting and preserving connective and support tissues
US5409911A (en) * 1992-09-11 1995-04-25 Merck & Co., Inc. Prostaglandin analog for treating osteoporosis
US5747660A (en) * 1995-11-06 1998-05-05 The University Of Colorado Nucleic acid encoding prostaglandin F2α receptor regulatory protein
US5703108A (en) * 1996-02-28 1997-12-30 Pfizer Inc. Bone deposition by certain prostaglandin agonists

Also Published As

Publication number Publication date
AR013479A1 (es) 2000-12-27
HUP0004581A2 (hu) 2001-05-28
US6156799A (en) 2000-12-05
ID24827A (id) 2000-08-24
PE119099A1 (es) 2000-02-03
AU9219298A (en) 1999-03-29
CO4980882A1 (es) 2000-11-27
TR200000662T2 (tr) 2000-07-21
CN1269721A (zh) 2000-10-11
KR20010023840A (ko) 2001-03-26
SK3412000A3 (en) 2000-12-11
PL339288A1 (en) 2000-12-04
JP2001515864A (ja) 2001-09-25
NO20001171L (no) 2000-05-09
AU739275B2 (en) 2001-10-11
WO1999012551A1 (en) 1999-03-18
IL134760A0 (en) 2001-04-30
EP1045694A1 (en) 2000-10-25
CA2303800A1 (en) 1999-03-18
BR9811780A (pt) 2000-09-12
ZA988228B (en) 1999-03-09

Similar Documents

Publication Publication Date Title
NO20001171D0 (no) FremgangsmÕte ved økning av benvolum under anvendelse av ikke naturlig forekommende FP-selektive agonister
AU1980600A (en) Agent for dying keratin fibers
DK0912406T3 (da) Forbedringer ved containere
GB2331936B (en) Apparatus for sampling blood
AU6156198A (en) Concave probe for arthroscopic surgery
EP1011559A4 (en) HYDROJET APPARATUS FOR REFRACTIVE SURGERY
GB0002685D0 (en) Beam splitting device
ZA973007B (en) Surgical instrument
AU1658897A (en) System for assessing bone characteristics
AU6262698A (en) Multimodality instrument for tissue characterization
EP0938881A4 (en) COLLAGEN-BASED AUXILIARY AGENT FOR OPHTHALMOLOGICAL SURGERY
AU7232298A (en) Surgical instrument for the transplantation of self-grown hair
DE69727692D1 (de) Atm verteilnetz
DE59707845D1 (de) Kryostatmikrotom
DE69840283D1 (de) Gerät zur Augenuntersuchung
AU3038500A (en) Agent for dying keratin fibers
DK0910319T3 (da) Anordning til benprotese
AU2002212116A1 (en) Agent for dyeing keratin containing fibers
ZA972386B (en) Tissue remodeling proteins.
AU2002363167A1 (en) Developer constituents and their use for dying keratin fibers
NO20014192D0 (no) Fremgangsmåte ved ökning av benvolum ved å anvende ikke naturlig forekommende EP-selektive agonister
GB9606525D0 (en) Surgical instrument
NO20001172D0 (no) FremgangsmÕte ved økning av benvolum
AU2011401A (en) Agent for colouring fibres containing keratin
AU1978900A (en) Agent for dying keratin fibers

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application